Here's Rare Earth Shares: Why They Surged This Week
USA Rare Earth's stock sprinted higher even as broader markets slipped. A major asset deal and clear production miles...
Stock indices move on earnings, policy changes, and macro data. This intro covers the core catalysts that drive daily swings.
23,761 articlesUSA Rare Earth's stock sprinted higher even as broader markets slipped. A major asset deal and clear production miles...
A major fund recently trimmed its stake in Viridian Therapeutics, signaling potential rotation rather than a verdict ...
A major fund recently sold its entire NIO position for about $79.8 million. This article breaks down what happened, w...
When rhythm pharma (rytm) releases earnings, investors get a window into revenue growth, cash health, and pipeline pr...
Geopolitical tensions in the Middle East have stirred oil markets and lifted energy stocks. Here’s how Occidental Pet...
The weight loss drug space has become a focus for growth-minded investors. This guide weighs Eli Lilly's proven progr...
Rivian has faced a choppy 2026 after huge 2025 gains. This piece explains why april could turning point for Rivian in...
Biotech investors watched Agios Pharmaceuticals spark a notable rally after key quarterly results and a strong Aqvesm...
U.S. markets climbed as Cisco impressed with earnings and Cerebras Systems began trading. The AI-driven rally helped ...
Cerebras exploded higher on its debut, but what comes next for investors? This guide breaks down the hype, the fundam...
As Micron prepares to report on June 24, three solid reasons could justify a closer look at MU. This guide breaks dow...
When a CEO discloses a sale of 41,600 shares, investors pay attention. This article unpacks the implications, the mec...